Anastasiia Kotaieva Sells 70,000 Shares of Nukkleus (NASDAQ:NUKK) Stock

Nukkleus Inc. (NASDAQ:NUKK) insider Anastasiia Kotaieva sold 70,000 shares of the stock in a transaction on Tuesday, December 23rd. The stock was sold at an average price of $4.57, for a total value of $319,900.00. Following the transaction, the insider directly owned 1,261,197 shares in the company, valued at approximately $5,763,670.29. This represents a 5.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Anastasiia Kotaieva also recently made the following trade(s):

• On Monday, December 29th, Anastasiia Kotaieva sold 75,000 shares of Nukkleus stock. The shares were sold at an average price of $4.09, for a total value of $306,750.00.
• On Friday, December 26th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The shares were sold at an average price of $4.26, for a total value of $236,873.04.
• On Wednesday, December 24th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.49, for a total value of $249,661.96.
• On Monday, December 22nd, Anastasiia Kotaieva sold 30,000 shares of Nukkleus stock. The shares were sold at an average price of $4.41, for a total value of $132,300.00.
• On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The shares were sold at an average price of $4.53, for a total transaction of $317,100.00.
• On Thursday, December 18th, Anastasiia Kotaieva sold 38,744 shares of Nukkleus stock. The stock was sold at an average price of $4.72, for a total transaction of $182,871.68.

Nukkleus Stock Performance

Nukkleus stock opened at $4.03 on Friday. Nukkleus Inc. has a 1 year low of $3.31 and a 1 year high of $40.98. The firm has a 50 day moving average price of $5.53 and a 200 day moving average price of $6.75. The company has a market cap of $67.10 million, a price-to-earnings ratio of 0.25 and a beta of -6.66.

Analysts Set New Price Targets

A number of brokerages recently weighed in on NUKK. Weiss Ratings reiterated a “sell (d+)” rating on shares of Nukkleus in a report on Wednesday, December 24th. Wall Street Zen upgraded Nukkleus from a “sell” rating to a “hold” rating in a report on Sunday, November 23rd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has an average rating of “Sell”.

Nukkleus News Summary

Here are the key news stories impacting Nukkleus this week:

• Positive Sentiment: Nukkleus completed the acquisition of Israeli defense-software firm Tiltan, adding ~30 years of defense AI expertise and established vendor relationships (IAI, Elbit, Rafael). This expands Nukkleus’s product set and creates a pathway to defense-market revenue. Nukkleus Completes Tiltan Acquisition
• Neutral Sentiment: Major outlets (MSN, TipRanks) circulated the acquisition news, increasing visibility; however, the announcements lack financial detail (purchase price, projected revenue, integration plan), so near‑term earnings impact is uncertain. TipRanks Announcement
• Negative Sentiment: Insider selling: director/officer Anastasiia Kotaieva sold several large blocks across Dec. 18–29 totaling roughly 286,208 shares for about $1.25M in proceeds (sales at ~$4.09–$4.72). Concentrated insider disposals can create selling pressure and be interpreted negatively by investors. SEC Filing (Insider Sales)

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets acquired a new position in shares of Nukkleus during the second quarter worth about $56,000. Ausdal Financial Partners Inc. purchased a new stake in shares of Nukkleus during the 3rd quarter valued at about $105,000. Finally, UBS Group AG lifted its position in Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after acquiring an additional 15,223 shares in the last quarter. 12.47% of the stock is owned by hedge funds and other institutional investors.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.